Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Impact Biolife Science Inc. has 1 pending office action in the Chemistry & Materials technology area. This matter is assigned to 1 distinct examiner, Hong Thi Yoo. The presence of only 1 pending office action indicates a focused prosecution effort, allowing for concentrated attention on the specific technical challenges raised by the examiner. This focused approach can facilitate a more specialized and efficient prosecution process for the pending application.
The active prosecution for the company is contained within 1 distinct art unit. Hong Thi Yoo is the busiest examiner for the portfolio, with 1 pending office action. This indicates a highly centralized and limited current engagement with the patent office. Such a focused profile suggests that the company's current intellectual property strategy is centered on a specific technical innovation within the chemistry field. This concentration allows for a focused legal strategy tailored to the specific art unit and examiner involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YOO, HONG THI | 1 | 46.0% | +25.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728279 | IMPROVED BIOLOGICALLY DERIVED FOOD PRESERVATIVE | YOO, HONG THI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728279 | IMPROVED BIOLOGICALLY DERIVED FOOD PRESERVATIVE | YOO, HONG THI | — |
| Art Unit | Apps |
|---|---|
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18728279 | IMPROVED BIOLOGICALLY DERIVED FOOD PRESERVATIVE | YOO, HONG THI | 1792 | §102§103§112 | Non-Final OA | — | Pending | Jul 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialImpact Biolife Science Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Hong Thi Yoo has the most, with 1 of Impact Biolife Science Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
